-
Sector Analysis
Personal Protective Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Personal Protective Equipment Market Overview The personal protective equipment market size was $48.35 billion in 2023. Factors such as the increasing volume of surgeries per year and technological advancement will drive the market growth at a CAGR of more than 7% during 2023-2033. Personal Protective Equipment (PPE) devices are used to minimize healthcare workers’ exposure to infectious agents. It will also help to maintain sterile environments when providing treatments to patients. PPE is required when medical procedures are performed on...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-1358894 in Borderline Personality Disorder (BPD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-1358894 in Borderline Personality Disorder (BPD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BI-1358894 in Borderline Personality Disorder (BPD) Drug Details: BI-1358894...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Personalized Neoantigen Tumor Vaccine in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Personalized Neoantigen Tumor Vaccine in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Personalized Neoantigen Tumor Vaccine in Solid Tumor Drug...
-
Analyst Opinions
NewUnited Kingdom (UK) Bancassurance Distribution Dynamics and Future Market, 2023 Update
United Kingdom (UK) Bancassurance Distribution Market Overview Bancassurance represents a strategic alliance between banks and insurance companies, designed to offer customers the convenience of purchasing insurance products in conjunction with banking services. The banking channel accounts for the highest share of total personal and commercial lines distribution in 2023. App purchases through the bank channel increased with no other channel recording a higher proportion of purchases via apps. This could be because of banks’ intensified focus on digitalization, resulting in...
-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
Generative Artificial Intelligence (AI) in Healthcare Report Overview GenAI is generating considerable buzz within the healthcare sector, from news updates to deal negotiations and company filings primarily to drive down costs and optimize administrative workflows, promising better healthcare. From accelerating R&D to easing administrative tasks and creating personalized patient experiences, genAI innovations have now proliferated across all the major healthcare application areas. The ’Generative Artificial Intelligence (AI) in Healthcare’ research report is a compendium of the latest real-world innovations in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Solid Tumor Personalized TCR-T in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Solid Tumor Personalized TCR-T in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Solid Tumor Personalized TCR-T in Solid Tumor Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MRNA-0217/S001 Personalized Tumor Vaccine in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MRNA-0217/S001 Personalized Tumor Vaccine in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MRNA-0217/S001 Personalized Tumor Vaccine in Solid Tumor Drug...
-
Thematic Analysis
NewClean Label in Consumer Goods – Thematic Intelligence
This report focuses on how the pursuit of clean label credentials by consumer goods companies is changing the industry as a whole. The clean label theme can be understood as an easier-to-understand, more consumer-friendly label with products comprised of natural ingredients and fewer additives and artificial chemicals, as well as sustainable and ethical sourcing and production. The parameters of what constitutes a clean label product are subjective and there is no legal definition, meaning that brands must interpret what the...
-
Product Insights
NewLikelihood of Approval Analysis for Clostridium tetani Infections
Overview How likely is it that the drugs in Clostridium tetani Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Clostridium tetani Infections Overview Clostridium tetani infections are a serious disease...
-
Product Insights
NewLikelihood of Approval Analysis for Bordetella pertussis Infections
Overview How likely is it that the drugs in Bordetella pertussis Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bordetella pertussis Infections Overview Bordetella pertussis is a bacterium that causes...